Jian-Xing He to Surveys and Questionnaires
This is a "connection" page, showing publications Jian-Xing He has written about Surveys and Questionnaires.
Connection Strength
0.007
-
Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer. Lung Cancer. 2018 08; 122:32-37.
Score: 0.007